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Abstract: MgSO4 is used as a tocolytic agent. It is considered to be a calcium channel antagonist, but a different mechanism of 
its action might be involved. The aim of this study was to examine the contribution of calcium concentrations and potassium 
channels in the mechanism of MgSO4-mediated uterine relaxation. Isolated uteri from female Wister rats were treated with 
increasing MgSO4 concentrations (0.1-30 mM). MgSO4 induced dose-dependent inhibition of spontaneous activity. Addition 
of Ca2+ (6 mM and 12 mM) stimulated uterine contractile activity and attenuated the inhibitory activity of MgSO4. In order 
to analyze the role of different subtypes of potassium channels, Ca2+-stimulated uteri were pretreated with glibenclamide 
(Glib), a selective ATP-sensitive potassium channel inhibitor (KATP), tetraethylammonium (TEA), a non-specific inhibitor of 
large conductance calcium-activated potassium channels (BKCa), and 4-aminopyridine (4-AP), a voltage-sensitive potassium 
channel inhibitor (Kv), at concentrations that had no effect per se. Pretreatment with 4-AP had no effect on MgSO4-mediated 
relaxation of Ca2+-stimulated uteri. The relaxing effect of MgSO4 was potentiated by pretreatment with glibenclamide. Pre-
treatment with TEA attenuated the MgSO4-mediated decrease in frequency. Our results suggest that MgSO4 acts as a general 
calcium antagonist that influences Ca2+-mediated potassium channels. Furthermore, it seems that MgSO4 uterine relaxation 
activity is partially mediated by selective ATP-sensitive potassium channels, suggesting an ATP-dependent role.
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INTRODUCTION
Magnesium sulfate (MgSO4, mineral salt, soluble in 
water) is used as a laxative, tocolytic agent and it is 
known as a functional blocker of calcium channels 
[1,2]. Despite the long-standing experience of its ap-
plication, the use of MgSO4 in gynecology has been a 
source of controversy for years. MgSO4 was first used in 
1906 to prevent eclamptic attacks by Horn in Germany, 
when administered intrathecally [3]. Its intramuscular 
use was first performed in 1926 to prevent repeated 
attacks in women with eclampsia [4], while the first 
intravenous administration was in 1933 to women 
with eclampsia and preeclampsia [5].
The tocolytic effects of MgSO4 were originally 
described by Hall et al. in 1959 [6]. Stallworth et. al. 
(1981) found a slight decrease in the incidence of 
uterine contractions, but no significant change in the 
intensity of contractions during MgSO4 administration 
[7]. Meta-analysis has shown that that magnesium 
reduces the risk of birth within 48 h by 15%, but it is 
considered not significant [8]. However, a combina-
tion of a betamimetic agonist and MgSO4 has been 
introduced, and studies have shown its efficiency 
in prolonging gestation [9-11]. On the other hand, 
tocolytic efficacy was not improved and side effects 
were increased [12]. Although there are many studies 
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dealing with the tocolytic effect of MgSO4, the exact 
mechanism of its action is still unknown.
Different types of β2-adrenergic agonists, Ca2+ 
channel blocker, oxytocin receptor antagonist and 
nonsteroidal antiinflammatory drugs are also used 
as tocolytics, but their insufficient effectiveness and 
side effects compromise their preliminary use [13,14]. 
Therefore, agents with potential tocolytic characteristics 
are still needed, and they could include calcium antago-
nists, potassium channel openers and other vasodilators 
[15]. Potassium channels are abundant and active in 
the smooth muscle of the uterus [16-18]. Based on 
structure and function, the channels are categorized 
in different groups (Kv channels, BKCa channels, ATP-
sensitive potassium channels), and each group contains 
many subtypes and isoforms [19]. Large conductance 
calcium-activated potassium channels (BKCa) are domi-
nant and active in uterine smooth muscles, especially 
during gestation [20]. ATP-dependent potassium chan-
nels (KATP) in the smooth muscles of the uterus form 
the connection between the metabolic state of the cell 
and uterine contractility [20,21,22]. Therefore, study-
ing the influence of potassium channel modulators 
on uterine tissue has been suggested as important for 
finding new therapeutic concepts in the treatment of 
uterine contractility disturbances [15,23].
Although wide-scale examinations of drugs as 
modulators of contractility have been performed, a final 
therapeutic preference has been omitted [17,23,24]. 
MgSO4 is considered a general calcium antagonist, 
but the potential site of MgSO4 cellular physiological 
activity can also be at the level of potassium channels. 
Potassium channels are widespread in all living cells 
and very important for regulating cell membrane 
excitability [25]. Therefore, the aim of our study was 
to explore the effect of MgSO4 on uterine contractility 




All animals were treated according to directive 2010/63/
EU of the European Parliament on the protection of 
animals used for scientific purposes and experiments 
were approved by the Ethical Committee for the Use of 
Laboratory Animals of the Faculty of Medicine Foča, 
University of East Sarajevo, Decision No. 01-3-88. 
Animals were kept at 22°C, housed 3 per cage and fed 
ad libitum. Uteri from intact Wistar rats (250-300 g) 
in the estrus phase of the estrus cycle, determined by 
examination of a daily vaginal lavage [26], were used.
Reagents
MgSO4 was supplied by Galenika a.d. (Belgrade, Serbia). 
Tetraethylammonium, glibenclamide and 4-aminopyri-
dine were purchased from Sigma-Aldrich (St. Louis, 
MO, USA). Salts for De Jalon’s solution were obtained 
from Zorka Pharma (Šabac, Serbia), Merck (New Jersey, 
USA) and Centrohem d.o.o. (Stara Pazova, Serbia).
Isolated organ bath studies
All rats were killed by rapid decapitation. The uterine 
horns were rapidly excised, carefully cleaned of sur-
rounding connective tissue and mounted vertically 
in a 10-mL-volume organ bath containing De Jalon’s 
solution (NaCl 154 mM, KCl 5.6 mM, CaCl2 × 2H2O 
0.41 mM, NaHCO3 5.9 mM and glucose 2.8 mM), under 
1 g tension, aerated with 95% oxygen and 5% CO2 at 
37°C. Experiments were performed after an equilibra-
tion period of about 30 min. The effect of MgSO4 was 
examined on a spontaneously active uterus (incubated 
for 30 min in an organ bath in De Jalon’s solution at 
37°C, oxygenated with 95% of O2 and 5% CO2), as well 
as on calcium-stimulated (6 and 12 mM Ca2+, the latter 
was referred to as double Ca) uteri. In order to analyze 
the possible role of different subtypes of potassium 
channels, Ca2+-stimulated uteri (with 6 mM Ca2+) were 
pretreated individually with Glib (10-5 M), TEA (10-3 
M), or 4-aminopyridine (4-AP, 10-3 M). After 10 min, 
increasing concentrations of MgSO4 (0.1-30 mM) were 
added. Myometrial tension was recorded isometrically 
with a TSZ-04-E isolated organ bath and transducer 
(Experimetria, Budapest, Hungary) and an Ugo Basile 
isolated organ bath and a transducer (Gemonio, Italy).
Data analysis and statistical procedures
Statistical analyses (descriptive statistics, analysis of 
variance (ANOVA), post hoc tests, F-test and Student’s 
t test) were performed according to the protocols de-
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scribed by Hinkle et al. [27] and Manley [28]. Effects of 
the treatments on uterine contractions were calculated 
as the percentages of untreated control contractions. 
Each value is expressed as the mean±SD. Differences 
between groups were analyzed by two-way ANOVA 
on a logarithmic transformed data row, using con-
centrations and pretreatments as factors (ANOVA 
was considered statistically significant when p<0.05), 
and post hoc tested by Tukey’s HSD t-test. Since con-
centration-response curves were sigmoidal in shape, 
they were fitted according to Boltzmann functions 
(the concentration axis was logarithmic) and the EC50 
were calculated. Sigmoid curves were compared using 
the F-test. EC50 values were compared using Student’s 
t test (significance: p<0.05).
RESULTS
MgSO4 relaxed spontaneous uterine activity in a con-
centration-dependent manner with regard to frequency 
(Fig. 1A). There were no significant changes in ampli-
tude until complete cessation of contractions occurred 
(at the highest used MgSO4 concentration of 30 mM). 
The addition of Ca2+ (6 and 12 mM) caused intensive 
contractile activity, and these types of uterine activity 
were referred to as Ca2+- or double Ca2+-stimulated, 
according to the concentration of Ca2+ used. MgSO4 
also relaxed both Ca2+- and double Ca2+-stimulated 
active uteri in a concentration-dependent manner (Fig. 
1B and C; ANOVA significant concentration effect, 
p<0.001), but the concentration of MgSO4 necessary 
for relaxation of the Ca2+- and double Ca2+-stimulated 
active uteri was significantly higher (significant dif-
ference in EC50 values, ANOVA significant type and 
interaction effect, p<0.001, significant post hoc Tukey 
t-test; Fig. 1D). EC50 was 5 times higher for double 
Ca2+-stimulated uteri than for the spontaneously ac-
tive uterus. The addition of both single and double 
Ca2+ extended the MgSO4 -induced relaxation effect 
and shifted the sigmoid shape for the frequency to-
ward higher concentrations (significant F-test effect, 
p<0.05; Fig. 1D).
Pretreatment with 4-AP had no effect on MgSO4-
mediated relaxation of Ca2+-stimulated uteri (no sig-
nificant ANOVA pretreatment effect, no difference 
between either the sigmoidal fit curve shape or EC50; 
Fig. 2A and B). On the other hand, a relaxing effect 
of MgSO4 was potentiated by pretreatment with glib-
enclamide (Fig. 3A and B). Pretreatment with gliben-
clamide significantly deepened relaxation by decreasing 
frequency (significant ANOVA pretreatment effect, 
p<0.05). Pretreatment with glibenclamide lowered 
the concentrations of MgSO4 that were needed for 
relaxation (post hoc Tukey difference between degrees 
of relaxation by single equivalent concentration of 5 
and 10 mM). There was no difference between the 
MgSO4-induced relaxing effect of Ca2+-stimulated and 
glibenclamide pretreated uteri as regards the amplitude. 
Pretreatment with TEA led to the elevation of 
frequency (significant ANOVA pretreatment effect, 
Fig. 1. The effect of MgSO4 on uterine contractile activity under 
different Ca2+ concentrations. Graphs show original traces for A – 
spontaneously active, B – Ca2+-stimulated active, and C – double 
Ca2+-stimulated active. Results are presented as the means±SD 
(n=8) for frequency measurements (D). The results were compared 
by two-way ANOVA for the concentration of MgSO4 (C) and the 
type of contractile activity (T) as factors, and F values are presented. 
From the curves, the EC50 values were calculated, expressed as the 
mean±SD and compared by one-way ANOVA and post hoc Tukey’s 
t-test. Differences in the shape of curves were tested by the F-test.
8 Arch Biol Sci. 2019;71(1):5-11
p<0.001; Fig. 4A and 4B) after application of MgSO4 
concentrations above 1 mM (post hoc Tukey t test, 
p<0.001). However, there was no statistically significant 
difference between EC50 values for frequency since 
there were large distributions of data in the middle 
part of the TEA curve and therefore the SD was high. 
There was no difference between the MgSO4-relaxing 
effect of Ca2+-stimulated and TEA pretreated uteri 
regarding amplitude.
DISCUSSION
Our results showed that MgSO4 inhibited spontaneous 
uterine activity in a concentration-dependent manner, 
and that therefore it could be considered as a uterine 
relaxant. This effect was in the range from 1-30 mM in 
the ex vivo extra uterine fluid (the EC50 for frequency 
was 2.6 mM). These external MgSO4 concentrations 
are not toxic, but pharmacologically they are selective 
with regard to the dosage, i.e. the therapeutic window 
is rather narrow. Magnesium ion concentrations in the 
plasma and extracellular fluid are approximately 1.2-1.4 
mM. One-third is bound by albumin or other proteins 
and biochemical moieties [29]. This means that small 
increases in Mg2+ in the extra uterine fluid can slow 
down the spontaneous frequency, but for complete 
relaxation a 3-fold higher concentration is required. 
Literature data indicate that increasing human serum 
Mg2+ concentration by 4-6 mEq/L (2-3 mmol/L) de-
creases uterine activity in preterm labor [30]. However, 
our results with pretreatment with glibenclamide and 
TEA indicated that the effective MgSO4 concentration 
range might be under the influence of applied drugs 
that can shift its therapeutic potential.
Fig. 2. The effect of MgSO4 on contractile activity of uteri pretreated 
with 4-AP. Graphs show original traces for: A – Ca2+-stimulated 
active uteri pretreated with 4-AP. The results are presented as the 
means±SD (n=8) for frequency (B) measurements. The results 
were compared by two-way ANOVA for the concentration of 
MgSO4 (C) and the type of contractile activity (T) as factors, 
and F values are presented. From the curves, EC50 values were 
calculated, expressed as the mean±SD and compared by one-way 
ANOVA and post hoc Tukey’s t-test. Differences in the shape of 
curves were tested by the F-test.
Fig. 3. The effect of MgSO4 on contractile activity of uteri pretreated 
with glib. Graphs show original traces for: A – Ca2+-stimulated 
active uteri pretreated with Glib. The results are presented as the 
means±SD (n=8) for frequency (B) measurements. The results 
were compared by two-way ANOVA for the concentration of 
MgSO4 (C) and the type of contractile activity (T) as factors, 
and F values are presented. From the curves, EC50 values were 
calculated, expressed as the mean±SD and compared by one-way 
ANOVA and post hoc Tukey’s t-test. Differences in the shape of 
curves were tested by the F-test.
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Our study showed that the addition of Ca2+ to 
the isolated organ bath prior to MgSO4 significantly 
attenuated the relaxing effect of MgSO4. Addition of 
the single Ca2+ concentration provoked an increase of 
the force of spontaneous contractions by elevating both 
amplitude and frequency. This increase was addition-
ally elevated by the double concentration Ca2+. In both 
cases, MgSO4 inhibited contractile activity, suggesting 
its physiological role as a general Ca2+ antagonist. It is 
known that Mg2+ inhibits the ryanodine receptor (RyR) 
Ca2+-release channels by competing with Ca2+ at the 
cytosolic activation sites of the channel in the mM range 
[31-33] and influences the fidelity of coupling between 
L-type Ca2+channels and RyRs [34]. On the other hand, 
cytosolic levels of H+, Ca2+, adenine nucleotides and 
Mg2+ during fatigue influence the gating properties of 
the SR Ca2+ channel [35], and the functional roles of 
the three main intracellular ions, Na+, Ca2+ and Mg2+, 
are modulated by calmodulin connected voltage-gated 
Na+ channels [36].
Since increasing concentrations of Ca2+ inhibited 
the relaxing effect of MgSO4 only in part, this indicated 
the existence of additional cellular signaling pathways 
that Mg2+ could operate through. Therefore, we partially 
inhibited potassium channels by different inhibitors 
prior to the addition of MgSO4. Our results showed 
that the voltage-gated KV subfamilies of potassium 
channels KV1-KV4 were not involved in the inhibitory 
action of Mg2+, since pretreatment with 4-AP had no 
effect on concentration-dependent Mg2+-promoted 
uterine relaxation. On the other hand, pretreatment 
with TEA modified the relaxing activity of MgSO4. 
TEA is a potent inhibitor of voltage-gated KV1-KV4 
subfamilies of potassium channels, but it also inhibits 
KV7 (KCQN) as well as BKCa potassium channel sub-
families, suggesting that KCQN as well as BKCa channels 
operated during the MgSO4-induced relaxant effect. 
In our experiment, pretreatment with TEA attenuated 
the relaxing effect as regards the frequency. Given that 
XE991, a KCNQ channel inhibitor, elevated the fre-
quency of the murine myometrium [37], it seems that 
the partial blockade of the potassium channels’ pore 
by TEA in our experiment contributed to the elevated 
frequency, and that MgSO4 operated as a mild KCQN 
channel inhibitor. It is known that intracellular Mg2+ 
enhances the function of BKCa potassium channels [38] 
through distinct binding sites and the activation is not 
directly affected either by voltage or Ca2+. However, 
TEA is also an efficient blocker of this type of channel, 
and its suppression contributed to other mechanisms 
of Mg2+-induced inhibition of uterine contractility. 
Moreover, BKCa channels are in neuronal cells colocal-
ized with voltage-dependent Ca2+ channels [39,40,41] 
or RYR [42], and these functional couples seem to be 
responsive to the Ca2+ entering into the cytosol and to 
the control Ca2+ concentration [40,42,43]. Shi and Cui 
[38] demonstrated that the competitive inhibition of 
Ca2+-dependent activation of BKCa channels by Mg2+ 
results in a significant reduction of the Mg2+-dependent 
activation at [Ca2+]i of ~0.1-100 μM. Taken together, our 
results suggest that the overall interplay between Ca2+ 
and Mg2+ is concentration-dependent. Blocking BKCa 
requires more Ca2+ that is prevented by the presence of 
Mg2+. On the other hand, if the Ca2+ concentration is 
Fig. 4. The effect of MgSO4 on contractile activity of uteri pretreated 
with TEA. Graphs show original traces for: A – Ca2+-stimulated 
active uteri pretreated with TEA. The results are presented as the 
means±SD (n=8) for frequency (B) measurements. The results 
were compared by two-way ANOVA for the concentration of 
MgSO4 (C) and the type of contractile activity (T) as factors, 
and F values are presented. From the curves, EC50 values were 
calculated, expressed as the mean±SD and compared by one-way 
ANOVA and post hoc Tukey’s t-test. Differences in the shape of 
curves were tested by the F-test.
10 Arch Biol Sci. 2019;71(1):5-11
in physiological balance with Mg2+, after the addition 
of Mg2+, its Ca2+ antagonist role is potentiated.
Magnesium interacts with organic phosphates such 
as ATP and PIP2. Intracellular Mg2+ depresses KCNQ 
currents by binding to PIP2 electrostatically, thus reduc-
ing the availability of PIP2 for direct interaction with 
the channels [44]. Most of cytoplasmic Mg2+ is in the 
form of a complex with ATP, phosphonucleotides and 
phosphometabolites and Mg2+, with ATP constituting 
the largest metabolic pool capable of binding Mg2+ 
within the cytoplasm and the mitochondrial matrix as 
well [45,46]. Our results showed that a partial block-
ade of KATP channels by glibenclamide stimulated the 
relaxing activity of MgSO4, which points to its ATP-
dependent role.
The results presented in our study show that MgSO4 
acts only partially as a general calcium antagonist. 
Moreover, a part of its physiological pathway is through 
BKCa channels since the blocking of BKCa channels 
with TEA led to the stimulation of frequency. Since 
relaxing activity was predominantly achieved by the 
reduction of frequency, it seems that MgSO4 is a direct 
K+ channel inhibitor, but it also affects Ca2+ availability. 
Furthermore, the MgSO4 uterine relaxing activity is 
influenced by selective ATP-sensitive potassium chan-
nels suggesting also an ATP-dependent role.
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